Keyse C. Silva
Salvador, BA 40296710, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
In silico and in vitro investigation of the safety and immunomodulatory mechanisms of 7-hydroxyflavone.
Journal: Chemico-biological interactions
Published: November 16, 2025
The Alkaloid Caulerpin Exhibits Potent and Selective Anti-Inflammatory Activity Through Interaction with the Glucocorticoid Receptor.
Journal: Marine drugs
Published: May 03, 2025
Physalin F, a Potent Inhibitor of Lymphocyte Function, Is a Calcineurin Inhibitor and Has Synergistic Effect with Dexamethasone.
Journal: Molecules (Basel, Switzerland)
Published: January 04, 2025
Solidagenone from Solidago chilensis Meyen Protects against Acute Peritonitis and Lipopolysaccharide-Induced Shock by Regulating NF-κB Signaling Pathway.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 28, 2023
Molecular Hybridization Strategy on the Design, Synthesis, and Structural Characterization of Ferrocene-N-acyl Hydrazones as Immunomodulatory Agents.
Journal: Molecules (Basel, Switzerland)
Published: September 26, 2022
Therapeutic Applications of Physalins: Powerful Natural Weapons.
Journal: Frontiers in pharmacology
Published: January 28, 2022
A Betulinic Acid Derivative, BA5, Induces G0/G1 Cell Arrest, Apoptosis Like-Death, and Morphological Alterations in Leishmania sp.
Journal: Frontiers in pharmacology
Published: December 30, 2021
Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy.
Journal: Frontiers in cellular and infection microbiology
Published: August 27, 2021
In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an N-Acyl Hydrazone Derivative Phosphodiesterase-4 Inhibitor, Against Leishmania amazonensis.
Journal: Frontiers in pharmacology
Published: August 01, 2020
Potent immunosuppressive activity of a phosphodiesterase-4 inhibitor N-acylhydrazone in models of lipopolysaccharide-induced shock and delayed-type hypersensitivity reaction.
Journal: International immunopharmacology
Published: May 14, 2018
Betulinic acid derivative BA5, a dual NF-kB/calcineurin inhibitor, alleviates experimental shock and delayed hypersensitivity.
Journal: European journal of pharmacology
Published: June 10, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026